The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism
Completed
- Conditions
- Idiopathic Hypogonadotropic Hypogonadism
- Interventions
- Registration Number
- NCT02042638
- Lead Sponsor
- Gulhane School of Medicine
- Brief Summary
Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic hypogonadism.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 16
Inclusion Criteria
Serum testosterone concentration < 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -
Exclusion Criteria
Previous androgen treatment, diabetes mellitus, arterial hypertension other hormone deficiencies
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 16 treatment naive Hypogonadotropic hypogonadism patients Pregnyl (hCG) ampule 1500 IU/three times a week Treatment naive 16 patients with idiopathic hypogonadotrophic hypogonadism 16 treatment naive Hypogonadotropic hypogonadism patients hCG 1500 IU three times a week Treatment naive 16 patients with idiopathic hypogonadotrophic hypogonadism
- Primary Outcome Measures
Name Time Method HDL after hCG treatment 2011-2013 2011-2013
total cholesterole levels after hCG treatment 2011-2013 LDL levels after hCG treatment 2011-2013
- Secondary Outcome Measures
Name Time Method Body fat ratio after hCG treatment 2011-2013 hsCRP levels after hCG treatment 2011-2013
Trial Locations
- Locations (1)
Gulhane School of Medicine Dep. of Endocrinology and Metabolism
🇹🇷Ankara, Turkey